Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$241.42 - $282.29 $982,579 - $1.15 Million
-4,070 Reduced 97.79%
92 $24,000
Q3 2022

Oct 25, 2022

BUY
$247.06 - $1507.4 $785,897 - $4.8 Million
3,181 Added 324.26%
4,162 $1.08 Million
Q2 2022

Aug 01, 2022

BUY
$237.11 - $299.66 $232,604 - $293,966
981 New
981 $249,000
Q4 2021

Jan 31, 2022

SELL
$292.08 - $329.01 $639,947 - $720,860
-2,191 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$272.21 - $332.43 $573,274 - $700,097
2,106 Added 2477.65%
2,191 $667,000
Q1 2021

May 03, 2021

SELL
$212.38 - $245.9 $43,325 - $50,163
-204 Reduced 70.59%
85 $19,000
Q4 2020

Jan 29, 2021

BUY
$212.5 - $245.46 $61,412 - $70,937
289 New
289 $64,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Qvr LLC Portfolio

Follow Qvr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qvr LLC with notifications on news.